
Seven inspection and test methods (revised replacements and new additions) are incorporated into the STSC.

Seven inspection and test methods (revised replacements and new additions) are incorporated into the STSC.

On October 15, 2026, China's NIDC published landmark draft standards for freeze-dried and single-dose cosmetics. Open for public feedback until November 22, 2026, the drafts establish unified testing requirements while excluding freeze-dried masks and trial samples, urging businesses to review formulations and plan compliance early. (51 words)
CIRS Group has summarized the latest global cosmetic regulatory developments of September 2026 to help enterprises gain a comprehensive view of global regulatory trends.

On August 6, 2026, China NIFDC publicly solicited comments on nine cosmetic standards invloving eight cosmetic ingredients and one testing method in STSC.

CIRS Group has compiled and summarized the latest global cosmetic regulatory developments of June 2026.

Technical Summary Based on the Latest OECD Guideline No. 497.

CIRS Group has compiled the sampling-inspection data and typical violations in June to help enterprises keep abreast of market-supervision trends and identify compliance risks.

Not all cosmetic test reports are created equal: some are rejected by regulators, and some aren’t internationally recognized. Choosing the wrong laboratory can delay your product launch or even block market entry entirely. This article explains the differences between CMA, CNAS, and ISO 17025 accreditation, why they matter for cosmetic testing in China, and how to select the right lab for regulatory compliance.

On May 29, 2026, China's STSC underwent a significant update. To accompany this update, China's NIFDC simultaneously released official supporting Q&As. CIRS Group has compiled and organized the information below for your reference.

On February 2, 2026, the Taiwan Food and Drug Administration (TFDA), under the Ministry of Health and Welfare, announced a revision to the annex of the Documentation Required for Case-by-Case Review of Applications for the Use of Human Cell-Derived Exosomes in Cosmetics. The revised annex takes effect immediately upon the date of announcement.